JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 11, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/24/25489    most recent
M313534200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deval, J.
Right arrow Articles by Canard, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deval, J.
Right arrow Articles by Canard, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 23, 2004
J. Biol. Chem, 10.1074/jbc.M313534200
Submitted on December 10, 2003
Revised on March 23, 2004
Accepted on March 23, 2004

A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions

Jerome Deval, Jean-Marc Navarro, Boulbaba Selmi, Jerome Courcambeck, Joelle Boretto, Philippe Halfon, Sarah Garrido-Urbani, Josephine Sire, and Bruno Canard

Centre National de la Recherche Scientifique and Université Aix-Marseille I and II, UMR 6098, Marseille, Cedex 09 13288

Corresponding Author: bruno{at}afmb.cnrs-mrs.fr

Mechanisms governing viral replicative capacity are poorly understood at the biochemical level. Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) K65R or L74V substitutions confer viral resistance to 2´,3´-dideoxyinosine (ddI) in vivo. The two substitutions never occur together, and L74V is frequently found in patients receiving ddI while K65R is not. Here, we show that recombinant viruses carrying K65R and K65R/L74V display the same resistance level to ddI (about 9.5 fold) relative to wild-type. Consistent with this result, purified HIV-1 RT carrying K65R RT or K65R/L74V substitutions exhibits an 8-fold resistance to ddATP as judged by pre-steady state kinetics of incorporation of a single nucleotide into DNA. Resistance is due to a selective decrease of the catalytic rate constant kpol: 22-fold (from 7.2 to 0.33 s-1) for K65R RT and 84-fold (from 7.2 to 0.086 s-1) for K65R/L74V RT. However, the K65R/L74V virus replication capacity is severely impaired relative to that of wild-type virus. This loss of viral fitness is correlated to a poor ability of K65R/L74V RT to use natural nucleotides relative to wild-type RT: 15% that of wild-type RT for dATP, 36% for dGTP, 50% for dTTP, and 25% for dCTP. The order of incorporation efficiency is WT RT > L74V RT > K65R RT > K65R/L74V RT. Processivity of DNA synthesis remains unaffected. These results explain why the two mutations do not combine in the clinic, and might give a mechanism for a decreased viral fitness at the molecular level.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
S. Zelina, C.-W. Sheen, J. Radzio, J. W. Mellors, and N. Sluis-Cremer
Mechanisms by Which the G333D Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Facilitates Dual Resistance to Zidovudine and Lamivudine
Antimicrob. Agents Chemother., January 1, 2008; 52(1): 157 - 163.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
C. Dykes and L. M. Demeter
Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
Clin. Microbiol. Rev., October 1, 2007; 20(4): 550 - 578.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Sluis-Cremer, C.-W. Sheen, S. Zelina, P. S. A. Torres, U. M. Parikh, and J. W. Mellors
Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors
Antimicrob. Agents Chemother., January 1, 2007; 51(1): 48 - 53.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Dutartre, C. Bussetta, J. Boretto, and B. Canard
General Catalytic Deficiency of Hepatitis C Virus RNA Polymerase with an S282T Mutation and Mutually Exclusive Resistance towards 2'-Modified Nucleotide Analogues
Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4161 - 4169.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. M. Chartier, S. P. Blais, and M. Couture
A Weak Fe-O Bond in the Oxygenated Complex of the Nitric-oxide Synthase of Staphylococcus aureus
J. Biol. Chem., April 14, 2006; 281(15): 9953 - 9962.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. R. Miranda, M. Gotte, and D. R. Kuritzkes
The L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Counteracts Enhanced Excision of Zidovudine Monophosphate Associated with Thymidine Analog Resistance Mutations
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2648 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. A. Frankel, B. Marchand, D. Turner, M. Gotte, and M. A. Wainberg
Impaired Rescue of Chain-Terminated DNA Synthesis Associated with the L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2657 - 2664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.